O Yoshida

3.6k total citations
232 papers, 2.8k citations indexed

About

O Yoshida is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, O Yoshida has authored 232 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 67 papers in Pulmonary and Respiratory Medicine and 29 papers in Molecular Biology. Recurrent topics in O Yoshida's work include Bladder and Urothelial Cancer Treatments (30 papers), Kidney Stones and Urolithiasis Treatments (18 papers) and Urinary and Genital Oncology Studies (14 papers). O Yoshida is often cited by papers focused on Bladder and Urothelial Cancer Treatments (30 papers), Kidney Stones and Urolithiasis Treatments (18 papers) and Urinary and Genital Oncology Studies (14 papers). O Yoshida collaborates with scholars based in Japan, Brazil and United States. O Yoshida's co-authors include Yusaku Okada, Fritz H. Schroeder, Yasuo Mizutani, E. Mizuta, Naoki Yoshimura, Sadako Kuno, Yoshiyuki Kakehi, Tomonori Habuchi, Hiroyuki Yamada and Benjamin Bonavida and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

O Yoshida

223 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Yoshida Japan 25 774 715 609 530 293 232 2.8k
Kirstan K. Meldrum United States 41 1.1k 1.4× 1.3k 1.8× 270 0.4× 434 0.8× 576 2.0× 100 4.0k
Sachiyo Suita Japan 31 1.8k 2.3× 958 1.3× 411 0.7× 692 1.3× 167 0.6× 239 3.8k
Masashi Kato Japan 26 433 0.6× 464 0.6× 572 0.9× 641 1.2× 414 1.4× 158 2.6k
Seiji Wada Japan 25 472 0.6× 945 1.3× 369 0.6× 382 0.7× 67 0.2× 183 2.7k
Hideki Sakai Japan 25 458 0.6× 474 0.7× 290 0.5× 993 1.9× 216 0.7× 192 2.5k
Raimund Pichler United States 27 439 0.6× 966 1.4× 261 0.4× 333 0.6× 84 0.3× 45 3.0k
John M. Kissane United States 33 1.3k 1.7× 1.5k 2.1× 587 1.0× 1.9k 3.6× 107 0.4× 114 5.2k
Ruth McCracken United States 25 276 0.4× 1.3k 1.8× 444 0.7× 504 1.0× 93 0.3× 28 3.1k
Marc Benderitter France 37 649 0.8× 1.1k 1.6× 678 1.1× 724 1.4× 132 0.5× 138 4.1k
Lin Qi China 34 990 1.3× 1.6k 2.2× 627 1.0× 847 1.6× 385 1.3× 274 4.1k

Countries citing papers authored by O Yoshida

Since Specialization
Citations

This map shows the geographic impact of O Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Yoshida more than expected).

Fields of papers citing papers by O Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Yoshida. The network helps show where O Yoshida may publish in the future.

Co-authorship network of co-authors of O Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of O Yoshida. A scholar is included among the top collaborators of O Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Yoshida. O Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, O, et al.. (2024). Smart resilience through IoT‐enabled natural disaster management: A COVID‐19 response in São Paulo state. SHILAP Revista de lepidopterología. 6(3). 211–224. 4 indexed citations
3.
Yoshida, O, Shoko Kimura, Lei Dou, et al.. (2014). DAP12 Deficiency in Liver Allografts Results in Enhanced Donor DC Migration, Augmented Effector T Cell Responses and Abrogation of Transplant Tolerance. American Journal of Transplantation. 14(8). 1791–1805. 22 indexed citations
4.
Yamamoto, S., Masaomi Yamane, O Yoshida, et al.. (2011). Activations of Mitogen-Activated Protein Kinases and Regulation of Their Downstream Molecules After Rat Lung Transplantation from Donors After Cardiac Death. Transplantation Proceedings. 43(10). 3628–3633. 14 indexed citations
5.
Mizutani, Yasuo, Hiroyuki Nakanishi, O Yoshida, et al.. (2002). Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. European Journal of Cancer. 38(1). 167–176. 67 indexed citations
6.
Yoshida, O, et al.. (1999). Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Current Eye Research. 18(2). 117–124. 30 indexed citations
7.
Iwamoto, Hiroshi, Hironori Yoshida, O Yoshida, Atsuki Fukushima, & Hideki Ueno. (1999). Inhibitory effects of FK506 on the development of experimental allergic/immune-mediated blepharoconjunctivitis in Lewis rats by systemic but not by topical administration. Graefe s Archive for Clinical and Experimental Ophthalmology. 237(5). 407–414. 13 indexed citations
8.
Kakehi, Yoshiyuki, O Yoshida, Takahiro Segawa, et al.. (1994). [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].. PubMed. 40(10). 925–9. 6 indexed citations
9.
Okumura, Katsuzumi, et al.. (1994). Urinary excretion of mutagens and covalent DNA damage induced in the bladder and kidney after passive smoking in rats. Urological Research. 22(2). 93–97. 7 indexed citations
10.
Mizutani, Yasuo, Benjamin Bonavida, & O Yoshida. (1994). Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines. Urological Research. 22(4). 261–266. 4 indexed citations
11.
Kakehi, Yoshiyuki, et al.. (1993). [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].. PubMed. 39(12). 1227–32. 3 indexed citations
12.
Kohri, Kazunori, Yasuaki Ishikawa, Masanori Iguchi, et al.. (1993). Relationship between the incidence infection stones and the magnesium-calcium ratio of tap water. Urological Research. 21(4). 269–272. 20 indexed citations
13.
Hosokawa, S. & O Yoshida. (1991). Removal of silicon, aluminum and beta2-Microglobulin in chronic haemodialysis patients. International Urology and Nephrology. 23(3). 281–284. 5 indexed citations
14.
Hosokawa, S., Osamu Yamaguchi, & O Yoshida. (1991). Vanadium transfer during haemodialysis. International Urology and Nephrology. 23(4). 407–409. 3 indexed citations
15.
Okada, Yusaku, et al.. (1989). Stable formation of the nipple valve in Kock pouch for diversion of the urinary tract.. PubMed. 169(4). 315–8. 17 indexed citations
16.
Hosokawa, S. & O Yoshida. (1989). Vanadium in Patients Undergoing Chronic Haemodialysis. Nephrology Dialysis Transplantation. 4(4). 282–284. 7 indexed citations
17.
Okada, K, et al.. (1988). Study of the effect of an anti-androgen (Oxendolone) on experimentally induced canine prostatic hyperplasia. Urological Research. 16(2). 67–72. 14 indexed citations
18.
Kawamura, J, et al.. (1985). [Significance of Ga-67-citrate tomographic scan in renal cell carcinoma].. PubMed. 22(4). 491–9. 2 indexed citations
19.
Endo, K, Harumi Sakahara, Tetsuo Nakashima, et al.. (1984). Tumor Imaging by Monoclonal Antibodies Labeled with Radioactive Metal Ions. The Korean Journal of Nuclear Medicine. 18(2). 77–85. 1 indexed citations
20.
Yoshida, O, et al.. (1983). [A review of the cases of testicular tumors reported in the Annual of Pathological Autopsy Cases in Japan].. PubMed. 29(2). 155–68. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026